JAK1, or Janus kinase 1, is a member of the Janus kinase family of intracellular non-receptor tyrosine kinases. It serves as a critical component of various signaling pathways, particularly those mediated by cytokine receptors. These receptors, upon ligand binding, undergo conformational changes that activate associated JAKs. Upon activation, JAK1 phosphorylates tyrosine residues on the receptor, creating docking sites for downstream signaling molecules such as signal transducers and activators of transcription (STATs). Subsequently, STAT proteins are recruited to the activated receptor complex, where they are phosphorylated by JAK1. Once phosphorylated, STATs dimerize, translocate to the nucleus, and regulate the transcription of target genes involved in diverse cellular processes, including cell proliferation, differentiation, and immune responses.
Activation of JAK1 typically occurs in response to extracellular stimuli, such as cytokines, growth factors, and hormones, that bind to their respective receptors on the cell surface. Upon ligand binding, receptor-associated JAK1 is brought into close proximity, leading to trans-phosphorylation and activation of JAK1 kinase activity. This results in the propagation of downstream signaling cascades through phosphorylation of cytoplasmic substrates, such as STAT proteins. Additionally, activated JAK1 can also phosphorylate and activate other signaling molecules, including phosphoinositide 3-kinase (PI3K) and mitogen-activated protein kinase (MAPK), contributing to the complexity and versatility of cellular responses mediated by JAK1-dependent pathways. Overall, the activation of JAK1 is tightly regulated and serves as a crucial step in transducing extracellular signals into intracellular responses essential for various physiological processes.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Sorafenib | 284461-73-0 | sc-220125 sc-220125A sc-220125B | 5 mg 50 mg 500 mg | $57.00 $100.00 $250.00 | 129 | |
Sorafenib activates JAK1 indirectly by inhibiting multiple receptor tyrosine kinases, including VEGFR, PDGFR, and RAF, leading to JAK1 activation. | ||||||
Ruxolitinib | 941678-49-5 | sc-364729 sc-364729A sc-364729A-CW | 5 mg 25 mg 25 mg | $251.00 $500.00 $547.00 | 16 | |
Ruxolitinib directly activates JAK1 by binding to its ATP-binding site, resulting in conformational changes that enhance its kinase activity. | ||||||
Tyrphostin B42 | 133550-30-8 | sc-3556 | 5 mg | $26.00 | 4 | |
Tyrphostin B42 (AG-490) activates JAK1 indirectly by inhibiting the activity of the upstream kinase, JAK2, leading to enhanced activation of JAK1. | ||||||
Baricitinib | 1187594-09-7 | sc-364730 sc-364730A | 5 mg 25 mg | $200.00 $664.00 | ||
Baricitinib activates JAK1 by binding to the ATP-binding pocket of JAK1, promoting its phosphorylation and subsequent activation. | ||||||
Fludarabine | 21679-14-1 | sc-204755 sc-204755A | 5 mg 25 mg | $58.00 $204.00 | 15 | |
Fludarabine indirectly activates JAK1 by inhibiting adenosine deaminase, leading to accumulation of adenosine, which activates JAK1 signaling. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Curcumin activates JAK1 indirectly by inhibiting NF-κB, a negative regulator of JAK1, resulting in enhanced JAK1 activation. | ||||||
Piceatannol | 10083-24-6 | sc-200610 sc-200610A sc-200610B | 1 mg 5 mg 25 mg | $51.00 $71.00 $199.00 | 11 | |
Piceatannol activates JAK1 by directly binding to its SH2 domain, promoting its dimerization and subsequent activation. | ||||||
Betulinic Acid | 472-15-1 | sc-200132 sc-200132A | 25 mg 100 mg | $117.00 $344.00 | 3 | |
Betulinic acid activates JAK1 indirectly by inhibiting proteasomal degradation of JAK1, leading to its accumulation and activation. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG activates JAK1 indirectly by inhibiting protein tyrosine phosphatases, which dephosphorylate and inactivate JAK1, leading to its activation. | ||||||